"It's great that they're identifyinga potential problem, but to have it as a lead article in the New England Journal is not sensitive to the consequences" for patients who might stop taking their medicine, says Stuart Weiss, an NYU endocrinologist.
It said it was concerned with the report's conclusion that the Department of Enterprise, Trade and Investment (DETI) should have taken a lead in identifying the problem and have sought a solution.